Summary:
- Researchers have developed a novel brain imaging technique using PET scans to measure the levels of a specific protein associated with Huntington’s disease, providing a clearer biomarker for disease progression.
- This advancement offers a significant improvement in clinical trial monitoring, potentially allowing scientists to better evaluate the efficacy of experimental gene therapies and neuroprotective treatments for this currently incurable genetic condition.